Phosphofructokinase

Phosphofructokinase (PDB: 3O8O) from Saccharomyces cerevisiae

Created by: Yazan Alshawkani

            Phosphofructokinase (PDB: 6pf3O8O) from Saccharomyces cerevisiae is a multisubunit allosteric enzyme responsible for catalyzing the primary regulatory step in glycolysis: the phosphorylation of fructose 6-phosphate to fructose 1,6-biphosphate by ATP. Glycolysis is the first step of cellular respiration in which living cells break down glycose into small, energy-containing ATP molecules. The crystal structures of eukaryotic phosphofructokinases from Saccharomyces cerevisiae also represent how successive gene duplications and fusion in the protein have allowed the evolution of new functionalities.

            Phosphofructokinase plays an important catalytic role in transient glycolysis that enables mitochondrial fusion and the stimulation of the S phase entry. This protein is necessary to upregulate glycolysis at this stage of the cell cycle (8). Elevated temperatures can hasten pH decline until phosphofructokinase loses its activity. In most organisms, at a pH below 5.5, the phosphofructokinase loses activity and, hence, arrests the process of glycolysis because of the protein’s inability to perform its catalytic role. The deficiency of phosphofructokinase can interfere with the production of muscle glycogen and ultimately lead to glycogen storage disease that depresses the health of an individual (3). Additionally, oscillations are distributed in nature and the synchronization of oscillators are described at the cellular level of the phosphofructokinase in regards to the process of glycolysis. Specifically, the allosteric regulation of phosphofructokinase regulates the emergence of glycolytic oscillations, which determines the rate of the glycolysis occurring (1). Additionally, a glycolytic enzyme like phosphofructokinase can favor cancer cell proliferation through nonmetabolic function. It can participate in the cell cycle activation and can have an antipoptotic effect (6). The phosphofructokinase enzyme also plays a special steering function for the regulation of intermediary metabolism in the liver (7). It efficiently prepares glucose for catabolism and energy production to sufficiently support these liver cells.

            The molecular weight of phosphofructokinase in Saccharomyces cerevisiae is 169309.36 Da while its isoelectric point is 6.31 (4). In eukaryotes, PFKs are activated by fructose 2,6-biphosphate, a potent allosteric regulator that controls the rate of glycolysis, overrides inhibition by ATP, and makes PFK in higher organisms sensitive to the activities of the hormones insulin and glucagon. The model of the 12S Saccharomyces cerevisiae PFK (ScPFK) structure consists of 6068 amino acid residues, 97% of the recrystallized protein, in eight polypeptide chains (5). Eight molecules of the ligand Fructose-6-Phosphate and eight molecules of the ligand fructose-2,6-diphosphate are bound to the enzyme. The Fructose-6-phosphate and fructose-2,6-diphosphate are also considered the prosthetic group of the protein because they are required for the enzyme activity of phosphofructokinase. The associated fructose-6-phosphate ligand lies within the glycolysis metabolic pathway and is further phosphorylated to fructose-1,6-biphosphate. The associated fructose-2,6-diphosphate ligand is a metabolite that allosterically affects the activity of the enzyme PFK to regulate glycolysis. ScPFK also contains homologous α and β subunits and can form stable heterooctamers α4β4. The internal sequence duplication α and β subunits similar to that seen in mammalian PFKs propose that gene duplications lead to a functional diversification of the catalytic and effector sites, which has allowed eukaryotes to develop more complex control systems for glycolytic processes. The 6-phosphofructokinase subunit alpha and 6-phosphofructokinase subunit beta specifically catalyze the phosphorylation of D-fructose 6-phosphate to fructose 1,6-biphosphae by ATP, the first committing step of glycolysis. Each α subunit and β subunit can be divided into two domains, the N-terminal halves and the C-terminal halves, each resembling the prokaryotic PFK subunit. The interactions between these two subunits determine the location of the active and effector sites in the eukaryotic enzyme. When the N-terminal domain of the α subunit interacts with the N-terminal domain of the β subunit, or when their C-terminal domains behave in a similar fashion, dimerization occurs.

The alignment of the protein subunits, the binding and interactions between them the substrate Fru6-P and the activator Fru2,6-P2, and a comparison with EM studies reveal ScPFK structure to be in the active state. The N-terminal domain of the eukaryotic PFK subunit retains the catalytic role, while the C-terminal half has acquired a regulatory function. The relative orientation between the two halves of ScPFK is 75°, whereas the usual 46° observed for the enzyme occurs in the presence of inhibitory amounts of ATP (5). A β-D-Fru6-P is bounded between the subdomains of the N-terminal half of one subunit, and the ligand’s 6-phosphate group interacts with two basic side chains of the neighboring subunit. ATP binding cavities are also found in the N-terminal domains. The Fru2,6-P2 effector has eight possible sites on the inner surface of the ScPFK octamer. Each molecule binds in a cavity between the subdomains of the C-terminal domain of one subunit, while the ligand’s 6-phosphate group extends across the interface and interacts with two basic amino acid side chains of the neighboring C-terminal domain. Additionally, ionic interactions and hydrogen bonds, mainly between the basic amino acid side chains, take place between the F6P C 988 and the F6P D 982 residues, as well as between the FDP C 3 and FDP C 4 residues (5). Additionally, there are several residues that are required for the optimal activity of the activator and effector on the protein. The Arg-952 and Arg-665 residues in the α subunit and the Arg-935 and Arg-658 residues in the β subunit form a motif for binding the activator’s 2-phosphate, and these Arg residues specifically coordinate the phosphate group. The Glu-694 residue in α and the Glu-688 residue in β is between the Arg side chains and stabilizes them through hydrogen bonds. Additionally, His-488, His-481, His-859, and His-853 residues each interact with the 6-phosphate of the sugar. When protonated, these residues are likely to interfere with the binding of the sugar ligands and to counteract the stabilizing and activating effects of the ligands on the enzyme. Also, the mutation of the Asp-543 residue to Ala suggests that the binding of ADP at this site has a functional role. With the Phosphofructokinase proteins found in Saccharomyces cerevisiae, none were shown to be in alternate conformations, incorporated in drug complexes, or associate with metal ions.

The secondary structure of ScPFK is composed of 15% beta sheets, which is equivalent to 30 strands of 122 residues, and 47% alpha helices, which is equivalent 37 helices of 367 residues (5).  PSI Blast is a sequence similarity search method, in which a query protein or nucleotide sequence is compared to nucleotide or protein sequences in a target database to identify regions of local alignment and report those alignments that score, an E value, above a given score threshold. A score below 0.5 indicates high similarity between proteins (9). Also, the DALI server was used as a network service for comparing the protein structure of ScPFK in 3-dimensional. The coordinate of the query protein structure were submitted and Dali compared them against those in the Protein Data Bank. It compares tertiary structures of proteins and calculates the differences in intramolecular distances. A corresponding Z core was given for each protein; a score above 2 meant that the comparison protein had similar folds to the ScPFK. Dali server only works for proteins because it requires the amino acid backbone atoms to make comparison. The structure used to compare the phosphofructokinase found in Saccharomyces cerevisiae was the phosphofructokinase with an inhibited T-state (PDB: 6PFK) found in Geobacillus stearothermophilus.  With an E-value of 2e-121 and a Z score of 40.6, this protein was a sufficient choice as the comparison structure because its E value is well below 0.5 and its Z score is well above 2 (2). The primary sequence of ScPFK, structure, is twice as long (766 residues) compared to the primary sequence of 6PFK (319 residues) (2). Additionally, they have nearly identical secondary structure compositions, as 3O8O is 47% helical and 15% beta sheets. When the two different phosphofructokinase structures are superimposed, the structural similarities of the alpha and beta subunits of both molecules can be observed.  Furthermore, F6P and FDP are the ligands/prosthetic groups in 3O8O while 2-phosphoglycolic acid is the ligand chemical component in 6PFK. The crystal structures of 6PFK reveal close coupling between the change of quaternary structure and local changes triggered by binding of the allosteric effects. In the tetramer of 6PFK, these concerted changes link all the effector and substrate sites and accomodate for the change of affinity for the cooperative substrate.